VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced it has initiated a second pivotal Phase 3 study of avanafil, its investigational new drug for the treatment of erectile dysfunction (ED). Avanafil is a next-generation, fast-acting,

The conversation about male sexual dysfunction has grown from a whisper to a roar. From Bob Dole to Mike Ditka, erectile dysfunction, or ED, is no longer hush-hush as more men are talking more openly. Non-stop commercials convey help in the bedroom is just a prescription away. Generic synthroid pills no prescription

Auxilium
Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical
company, today announced that the first patients have been dosed in
the Company’s U.S. phase IIb trial of XIAFLEX(TM) for the treatment
of Peyronie’s disease. Peyronie’s disease is the development of a
collagen plaque, or scar tissue, on the shaft of the penis that
hardens and reduces flexibility, causing the penis to bend

A new service which allows men to get erectile dysfunction drugs legitimately without having to visit their GP for a prescription has been launched.
The new service - a UK first - is being launched by Lloydspharmacy in partnership with sexual health experts Dr Thom, The service offers online diagnosis of erectile problems

Coloplast announced today the first U.S. patient training with its new Titan® inflatable penile prosthesis with One-Touch Release (OTR) pump for men with erectile dysfunction who do not respond to traditional ED drug therapy.
"Coloplast is excited to launch the first true one-touch release penile implant that is designed for ease of patient training," said Jan […]

Buy generic lexapro Peyronie’s disease is characterized by a plaque, or hard lump, that develops on the upper or lower side of the penis in layers containing erectile tissue.